scholarly article | Q13442814 |
P2093 | author name string | You Han Bae | |
Dongin Kim | |||
Eun Seong Lee | |||
Zhong Gao Gao | |||
P2860 | cites work | Cancer nanotechnology: opportunities and challenges | Q29615481 |
Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
Targeting multidrug resistance in cancer | Q29616803 | ||
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
Drug delivery systems: entering the mainstream | Q29618136 | ||
Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation | Q31130651 | ||
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 | ||
Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells | Q33688530 | ||
Role of P-glycoprotein in drug disposition | Q33845762 | ||
Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs | Q34060806 | ||
Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 | ||
Anticancer prodrugs for application in monotherapy: targeting hypoxia, tumor-associated enzymes, and receptors | Q34319102 | ||
Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules | Q34408529 | ||
The cell biology of multiple drug resistance | Q34661261 | ||
Targeted drug delivery by thermally responsive polymers. | Q34804805 | ||
PEGylated nanoparticles for biological and pharmaceutical applications | Q35082131 | ||
Ligand-targeted liposomal anticancer drugs | Q35157616 | ||
Cell biological mechanisms of multidrug resistance in tumors | Q35179585 | ||
Multidrug resistance reversal agents | Q35570886 | ||
Liposome-based approaches to overcome anticancer drug resistance | Q35595419 | ||
Nanoparticle and targeted systems for cancer therapy | Q35879221 | ||
Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution | Q36684624 | ||
Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. | Q36920351 | ||
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells | Q37263033 | ||
Intracellular pH and the control of multidrug resistance | Q37558951 | ||
Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. | Q39925586 | ||
Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles | Q40104142 | ||
Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells | Q40154265 | ||
A bacterial protein enhances the release and efficacy of liposomal cancer drugs | Q40204842 | ||
Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry | Q40208632 | ||
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. | Q40277654 | ||
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system | Q40302466 | ||
Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier | Q40357454 | ||
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. | Q40447478 | ||
Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. | Q40470446 | ||
Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. | Q41188827 | ||
P-glycoprotein and multidrug resistance | Q41239416 | ||
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein | Q41578162 | ||
Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles | Q43089706 | ||
HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia | Q43901439 | ||
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes | Q43973334 | ||
Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma | Q44103318 | ||
Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization | Q44525531 | ||
Polymeric micelle for tumor pH and folate-mediated targeting | Q44558767 | ||
Auxin induces exocytosis and the rapid synthesis of a high-turnover pool of plasma-membrane H(+)-ATPase | Q47730735 | ||
Prodrug chemotherapeutics bypass p-glycoprotein resistance and kill tumors in vivo with high efficacy and target-dependent selectivity | Q47913323 | ||
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump | Q49062104 | ||
The design and synthesis of polymers for eukaryotic membrane disruption. | Q52536241 | ||
Differential macromolecular leakage from the vasculature of tumors | Q68951976 | ||
A novel rodent mammary window of orthotopic breast cancer for intravital microscopy | Q73245873 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
micelles | Q421110 | ||
folic acid | Q127060 | ||
P304 | page(s) | 1353-1362 | |
P577 | publication date | 2009-09-01 | |
P1433 | published in | Molecular Pharmaceutics | Q3011140 |
P1476 | title | In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer | |
P478 | volume | 6 |
Q36412928 | Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. |
Q37031597 | Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review |
Q40568410 | Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading. |
Q51025906 | Brushed block copolymer micelles with pH-sensitive pendant groups for controlled drug delivery. |
Q39365167 | CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells |
Q39062600 | Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy |
Q38067265 | Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. |
Q30421664 | Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics |
Q39559271 | Effect of local dual frequency sonication on drug distribution from polymeric nanomicelles. |
Q35560114 | Endosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel |
Q28073956 | Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective. |
Q38955404 | Enhanced synergism of thermo-chemotherapy by combining highly efficient magnetic hyperthermia with magnetothermally-facilitated drug release. |
Q38168377 | Exploring polymeric micelles for improved delivery of anticancer agents: recent developments in preclinical studies. |
Q38161447 | Extracellular stability of nanoparticulate drug carriers |
Q28486235 | Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor |
Q39115464 | Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle. |
Q35664403 | Folate-decorated nanogels for targeted therapy of ovarian cancer. |
Q83528769 | Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier |
Q39027223 | Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles |
Q53686098 | In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers. |
Q39296686 | In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer. |
Q39526281 | Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer |
Q38119471 | Multifunctional nanomicellar systems for delivering anticancer drugs. |
Q35809872 | Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery |
Q37798555 | Multifunctionality of lipid-core micelles for drug delivery and tumour targeting |
Q55018323 | Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention. |
Q37822160 | Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer |
Q38938291 | PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking |
Q53181077 | Photo-controlled metal-ion (Zn2+ and Cd2+) release in aqueous Tween-20 micelle solution. |
Q41057564 | Physicochemical characterization of drug nanocarriers. |
Q30478123 | Polymeric micelles in anticancer therapy: targeting, imaging and triggered release |
Q38575282 | Polymeric nanoparticles: the future of nanomedicine |
Q35023993 | Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles |
Q37997512 | Recent advances in drug delivery strategies for treatment of ovarian cancer |
Q37974590 | Recent advances in stealth coating of nanoparticle drug delivery systems |
Q90345858 | Redox-responsive biocompatible nanocarriers based on novel heparosan polysaccharides for intracellular anticancer drug delivery |
Q34459637 | Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy |
Q57341240 | Stimulation-Sensitive Drug Delivery Systems |
Q90169696 | Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment |
Q38062891 | Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery |
Q38032480 | Stimulus-responsive nanopreparations for tumor targeting |
Q38062884 | Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers. |
Q38928745 | Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo. |
Q38809044 | The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer |
Q33965271 | The benefits and challenges associated with the use of drug delivery systems in cancer therapy |
Q34615075 | The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. |
Q30354655 | Theranostic Probes for Targeting Tumor Microenvironment: An Overview. |
Q50504656 | Tunable pH-sensitive poly(β-amino ester)s synthesized from primary amines and diacrylates for intracellular drug delivery. |
Q37780547 | Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool |
Q34139159 | Zwitterionic chitosan derivatives for pH-sensitive stealth coating |
Q38127747 | pH- and ion-sensitive polymers for drug delivery |
Q38168593 | pH-sensitive drug-delivery systems for tumor targeting |
Q36653608 | pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery |
Q38205583 | pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances |
Search more.